Drugs that block enzymes called tyrosine kinases are among the most effective targeted therapies for cancer. However, they ...

After collecting an FDA approval earlier this year for local pancreatic cancer, Novocure is putting forward positive clinical ...

A team of cancer genomics scientists from The University of Manchester and The Institute of Cancer Research, London, ...

"The cancer cells are acting like they’re infected." ...

Several experimental prostate cancer drugs have produced striking results in early-stage clinical trials, with at least one ...

The challenge is that the tumor immune microenvironment is not a static backdrop but a constantly shifting ecosystem shaped by cancer cells, immune cells, stromal cells, cytokines, and physical ...

A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs.

Cancer’s strongest gene switches push DNA into damaging overdrive, creating repeated breaks and repairs that may fuel tumor ...

Fragments of tumor DNA circulating in the bloodstream of patients with breast cancer can predict whether they are likely to ...

Researchers compared clinicopathologic features, MammaPrint and BluePrint molecular subtype, and outcomes by race among patients with HR+, HER2− early-stage breast cancer.

A large observational analysis suggests that the presence of isolated tumor cells may signal worse survival in low-risk endometrial cancer.

The musician has been open about his health journey with fans by sharing updates on Instagram.